These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11961775)

  • 1. Complications of type 2 diabetes: renal disease and the promotion of patient self-management.
    Melville A; Richardson R; Lister-Sharp D
    Nurs Times; 2000 Apr 27-May 3; 96(17):37-8. PubMed ID: 11961775
    [No Abstract]   [Full Text] [Related]  

  • 2. On the evidence. Type 2 diabetes.
    Melville A; Richardson R; Lister-Sharp D
    Health Serv J; 2000 Mar; 110(5696):32-3. PubMed ID: 11067500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Should normotensive diabetic patients with microalbuminuria be treated with angiotensin converting enzyme inhibitors?].
    Feldt-Rasmussen BF
    Ugeskr Laeger; 2002 Apr; 164(14):1907-9. PubMed ID: 11957423
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
    Bilous R
    Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephropathy in patients with type 2 diabetes mellitus.
    Ritz E; Orth SR
    N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
    [No Abstract]   [Full Text] [Related]  

  • 9. ACE inhibition and renovascular disease.
    Carr S
    Diabet Med; 2001 Jan; 18 Suppl 1():4-6. PubMed ID: 11289190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Professional recommendations for follow-up of the type 2 diabetic patient excluding the follow-up of complications. National Agency for the Accreditation and Evaluation of Health].
    J Mal Vasc; 1999 Jun; 24(3):239-44. PubMed ID: 10467537
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):217-21. PubMed ID: 20228503
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal diseases in diabetes mellitus.
    Kumar PD; Rajaratnam K
    J Indian Med Assoc; 1997 Jul; 95(7):426-8. PubMed ID: 9425845
    [No Abstract]   [Full Text] [Related]  

  • 13. Microalbuminuria in diabetes mellitus.
    Tobe SW; McFarlane PA; Naimark DM
    CMAJ; 2002 Sep; 167(5):499-503. PubMed ID: 12240818
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications of diabetes: renal disease and promotion of self-management.
    Melville A; Richardson R; Lister-Sharp D; McIntosh A
    Qual Health Care; 2000 Dec; 9(4):257-63. PubMed ID: 11101711
    [No Abstract]   [Full Text] [Related]  

  • 15. Should all diabetic patients take ACE inhibitors, even those without proteinuria?
    Hoogwerf BJ
    Cleve Clin J Med; 1999 Apr; 66(4):208-9. PubMed ID: 10199056
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    Kidney Int; 2010 Mar; 77(5):375-7. PubMed ID: 20150934
    [No Abstract]   [Full Text] [Related]  

  • 18. Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P
    Ren Fail; 2005; 27(4):493-4. PubMed ID: 16060141
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of temocapril on the prevention of early diabetic nephropathy in OLETF rat, an animal model for type 2 diabetes].
    Masuda H
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):419-28. PubMed ID: 12404757
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical practice. Nephropathy in patients with type 2 diabetes.
    Remuzzi G; Schieppati A; Ruggenenti P
    N Engl J Med; 2002 Apr; 346(15):1145-51. PubMed ID: 11948275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.